Mostrando 9 resultados de: 9
Filtros aplicados
Área temáticas
Enfermedades(8)
Farmacología y terapéutica(4)
Medicina y salud(3)
Bioquímica(2)
Fisiología humana(2)
Área de conocimiento
Neurología(6)
Medicamento(3)
Biología molecular(2)
Bioquímica(2)
Medicina interna(2)
Antiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseases
ReviewAbstract: The purpose of this review is to discuss potential pathways involved in the pathogenesis of neurodegPalabras claves:Alzheimer's disease, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Neuroprotective drugs. apoptosis, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Sureda F.X., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusA chronological review of potential disease-modifying therapeutic strategies for Alzheimer's disease
ReviewAbstract: Late-onset Alzheimer’s disease (LOAD) is a neurodegenerative disorder that has become a worldwide hePalabras claves:Alzheimer’s disease, calcium, ER stress, glutamate, Neurodegeneration, neuroinflammation, Oxidative Stress, Parkinson’s DiseaseAutores:Antoni Camins, Auladell C., Busquets O., Espinosa-Jimenez T., Ettcheto M., Verdaguer E.Fuentes:scopusAdvances in the treatment of neurodegenerative diseases and epilepsy
ArticleAbstract:Palabras claves:Autores:Antoni CaminsFuentes:scopusNew targets and strategies of medical treatments in neurological and neurodegenerative disorders
OtherAbstract:Palabras claves:Autores:Antoni Camins, Zárate C.B.Fuentes:scopusNovel Insights into the Molecular Mechanisms Involved in the Neuroprotective Effects of C-Phycocyanin against Brain Ischemia in Rats
ArticleAbstract: Background: Ischemic stroke produces a large health impact worldwide, with scarce therapeutic optionPalabras claves:Brain ischemia, C-Phycocyanin, Ischemic stroke, NADPH oxidase, neuroinflammation, neuroprotectionAutores:Alexey Llópiz-Arzuaga, Antoni Camins, Cruz O.G., González I.H., Leopoldino A.M., Liberato J.L., Marín-Prida J., Pardo-Andreu G.L., Pavón-Fuentes N., Pentón-Rol G., Pérez M.L., Santos W.F.D., Stringhetta-Padovani K., Uyemura S.A.Fuentes:googlescopusMetabolic basis of sporadic Alzeimer’s disease. Role of hormones related to energy metabolism
ArticleAbstract: The more common sporadic form of Alzheimer disease (SAD) and the metabolic syndrome are two highly pPalabras claves:Adipokines, amylin, Ghrelin, leptin, prolactin, Sporadic Alzheimer diseaseAutores:Antoni Camins, Folch J., Martínez N., Patraca I., Pedros I., Sureda F.X.Fuentes:scopusMolecular and biochemical features in Alzheimer's disease
ReviewAbstract: The purpose of this review is to discuss the pathophysiological pathways involved in pathogenesis ofPalabras claves:Acetylcholine, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Presenilins, Secretases, β-AmyloidAutores:Antoni Camins, Pallás M.Fuentes:scopusReceptor to glutamate NMDA-type: The functional diversity of the NR1 isoforms and pharmacological properties
ArticleAbstract: Glutamic acid (Glu) is the major excitatory neurotransmitter in the central nervous system, and intePalabras claves:Excitotoxicity, Isoform, NMDA receptor, NR1 Subunit, NR2 SubunitAutores:Antoni Camins, Chaparro-Huerta V., Escoto-Delgadillo M., Flores-Soto M.E., Ureña-Guerrero M.E., Zárate C.B.Fuentes:scopusTherapeutic Strategies for Neurological Disorders: From Natural Compounds to Innovative Molecular Designs
OtherAbstract:Palabras claves:Autores:Antoni Camins, Ettcheto M.Fuentes:scopus